Doyle Mittie

CIK 00019188453 companiesWAYNE, PA

SEC Profile

Transactions

Companies

Filings

CIK

0001918845

Recent Transactions

50 trades

Exercise/Conversion
Avalo Therapeutics, Inc.$AVTX
Common Stock
2026-08-28$8.04/sh+679→ 52,455 total
Exercise/Conversion
Avalo Therapeutics, Inc.$AVTX
Stock Option (Right to Buy)
2026-08-28−679→ 113,734 total
Sale
Avalo Therapeutics, Inc.$AVTX
Common Stock
2026-08-28$20.00/sh−679→ 51,776 total
Exercise/Conversion
Avalo Therapeutics, Inc.$AVTX
Common Stock
2026-08-17$12.65/sh+1,000→ 52,776 total
Sale
Avalo Therapeutics, Inc.$AVTX
Common Stock
2026-08-17$20.00/sh−1,000→ 51,776 total
Exercise/Conversion
Avalo Therapeutics, Inc.$AVTX
Stock Option (Right to Buy)
2026-08-17−1,000→ 123,750 total
Sale
Avalo Therapeutics, Inc.$AVTX
Common Stock
2026-08-10$20.00/sh−679→ 51,776 total
Exercise/Conversion
Avalo Therapeutics, Inc.$AVTX
Stock Option (Right to Buy)
2026-08-10−679→ 114,413 total
Exercise/Conversion
Avalo Therapeutics, Inc.$AVTX
Common Stock
2026-08-10$8.04/sh+679→ 52,455 total
Exercise/Conversion
Avalo Therapeutics, Inc.$AVTX
Stock Option (Right to Buy)
2026-07-27−1,000→ 124,750 total
Exercise/Conversion
Avalo Therapeutics, Inc.$AVTX
Common Stock
2026-07-27$12.65/sh+1,000→ 52,776 total
Sale
Avalo Therapeutics, Inc.$AVTX
Common Stock
2026-07-27$20.00/sh−1,000→ 51,776 total
Exercise/Conversion
Avalo Therapeutics, Inc.$AVTX
Common Stock
2026-06-30$8.04/sh+1,779→ 56,430 total
Exercise/Conversion
Avalo Therapeutics, Inc.$AVTX
Stock Option (Right to Buy)
2026-06-30−1,779→ 115,092 total
Exercise/Conversion
Avalo Therapeutics, Inc.$AVTX
Stock Option (Right to Buy)
2026-06-30−2,875→ 125,750 total
Sale
Avalo Therapeutics, Inc.$AVTX
Common Stock
2026-06-30$20.00/sh−4,654→ 51,776 total
Exercise/Conversion
Avalo Therapeutics, Inc.$AVTX
Common Stock
2026-06-30$12.65/sh+2,875→ 54,651 total
Sale
Avalo Therapeutics, Inc.$AVTX
Common Stock
2026-06-23$18.00/sh−1,450→ 51,776 total
Exercise/Conversion
Avalo Therapeutics, Inc.$AVTX
Stock Option (Right to Buy)
2026-06-23−1,450→ 116,871 total
Exercise/Conversion
Avalo Therapeutics, Inc.$AVTX
Common Stock
2026-06-23$8.04/sh+1,450→ 53,226 total
Award
Cullinan Therapeutics, Inc.$CGEM
Stock Option (Right to Buy)
2026-06-16+21,781→ 21,781 total
Tax Payment
Avalo Therapeutics, Inc.$AVTX
Common Stock
2026-06-10$13.10/sh−1,084→ 51,776 total
Exercise/Conversion
Avalo Therapeutics, Inc.$AVTX
Common Stock
2026-05-28$8.04/sh+679→ 47,801 total
Exercise/Conversion
Avalo Therapeutics, Inc.$AVTX
Stock Option (Right to Buy)
2026-05-28−679→ 118,321 total
Sale
Avalo Therapeutics, Inc.$AVTX
Common Stock
2026-05-28$16.00/sh−679→ 47,122 total
Award
Avalo Therapeutics, Inc.$AVTX
Common Stock
2026-05-21+43,500→ 47,122 total
Exercise/Conversion
Avalo Therapeutics, Inc.$AVTX
Stock Option (Right to Buy)
2026-05-15−3,000→ 128,625 total
Exercise/Conversion
Avalo Therapeutics, Inc.$AVTX
Common Stock
2026-05-15$12.65/sh+3,000→ 6,622 total
Sale
Avalo Therapeutics, Inc.$AVTX
Common Stock
2026-05-15$18.76/sh−3,000→ 3,622 total
Sale
Avalo Therapeutics, Inc.$AVTX
Common Stock
2026-05-06$18.03/sh−27,538→ 82,639 total
Exercise/Conversion
Avalo Therapeutics, Inc.$AVTX
Common Stock
2026-05-06$8.04/sh+28,650→ 110,177 total
Exercise/Conversion
Avalo Therapeutics, Inc.$AVTX
Common Stock
2026-05-06$12.65/sh+77,905→ 81,527 total
Exercise/Conversion
Avalo Therapeutics, Inc.$AVTX
Stock Option (Right to Buy)
2026-05-06−28,650→ 119,000 total
Exercise/Conversion
Avalo Therapeutics, Inc.$AVTX
Stock Option (Right to Buy)
2026-05-06−77,905→ 131,625 total
Sale
Avalo Therapeutics, Inc.$AVTX
Common Stock
2026-05-06$22.88/sh−10,058→ 3,622 total
Sale
Avalo Therapeutics, Inc.$AVTX
Common Stock
2026-05-06$22.41/sh−19,015→ 13,680 total
Sale
Avalo Therapeutics, Inc.$AVTX
Common Stock
2026-05-06$21.20/sh−44,944→ 32,695 total
Sale
Avalo Therapeutics, Inc.$AVTX
Common Stock
2026-05-06$19.65/sh−5,000→ 77,639 total
Exercise/Conversion
Avalo Therapeutics, Inc.$AVTX
Common Stock
2026-05-05$8.04/sh+679→ 5,301 total
Exercise/Conversion
Avalo Therapeutics, Inc.$AVTX
Stock Option (Right to Buy)
2026-05-05−679→ 147,650 total
Exercise/Conversion
Avalo Therapeutics, Inc.$AVTX
Stock Option (Right to Buy)
2026-05-05−1,000→ 209,530 total
Sale
Avalo Therapeutics, Inc.$AVTX
Common Stock
2026-05-05$16.00/sh−1,679→ 3,622 total
Exercise/Conversion
Avalo Therapeutics, Inc.$AVTX
Common Stock
2026-05-05$12.65/sh+1,000→ 4,622 total
Sale
Avalo Therapeutics, Inc.$AVTX
Common Stock
2026-04-06$18.01/sh−3,970→ 3,622 total
Exercise/Conversion
Avalo Therapeutics, Inc.$AVTX
Stock Option (Right to Buy)
2026-04-06−3,970→ 210,530 total
Exercise/Conversion
Avalo Therapeutics, Inc.$AVTX
Common Stock
2026-04-06$12.65/sh+3,970→ 7,592 total
Sale
Avalo Therapeutics, Inc.$AVTX
Common Stock
2026-04-01$16.00/sh−679→ 3,622 total
Exercise/Conversion
Avalo Therapeutics, Inc.$AVTX
Stock Option (Right to Buy)
2026-04-01−679→ 148,329 total
Exercise/Conversion
Avalo Therapeutics, Inc.$AVTX
Common Stock
2026-04-01$8.04/sh+679→ 4,301 total
Exercise/Conversion
Avalo Therapeutics, Inc.$AVTX
Common Stock
2026-03-16$8.04/sh+5,992→ 29,114 total

Companies

Recent Filings

Address

C/O AVALO THERAPEUTICS, INC. 1500 LIBERTY RIDGE DRIVE, SUITE 321

WAYNE, PA, 19087

View on SEC.gov